The University of Arizona’s Precision Aging Network will release its first comprehensive dataset on normal cognitive aging in December 2025. This initiative, part of a broad...
Research into chronic traumatic encephalopathy, or CTE, has uncovered significant genetic damage in the brains of individuals suffering from this neurological disease. Traditionally associated with athletes...
Algernon Pharmaceuticals has officially changed its name to Algernon Health, marking a significant shift in its corporate strategy. The new name will be reflected in trading...
A recent study conducted by researchers at University College London reveals that up to 33% of Alzheimer’s disease cases could potentially be avoided by mitigating specific...
UPDATE: A shocking report reveals that dementia cases in Canada are set to exceed 1 million by 2030, with current estimates indicating that approximately 750,000 Canadians...
Research indicates that cats experiencing dementia exhibit brain changes similar to those seen in humans with Alzheimer’s disease. A recent study reveals that the accumulation of...
Alberta’s healthcare system is at a critical juncture as new therapies for Alzheimer’s disease emerge, presenting both an opportunity and a challenge for patient care. For...
